Metraipolis › archive › dc_09c6df2b52bb

Systemic immunologic effects of long-term dupilumab treatment in severe eosinophilic asthma beyond clinical outcomes — Europe PMC PMID:42440605

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42440605
DOI
10.3389/falgy.2026.1873964
License (as archived)
solo-consultazione
Archived
2026-10-19T07:07:45.114Z
SHA-256 of the archived text
ff0a59dc133c7737692abd2a71815f756cde48ab29d617db9b35382a1c1de7c0
Stable URL of this page
https://metraipolis.com/documento/dc_09c6df2b52bb

How to cite

Systemic immunologic effects of long-term dupilumab treatment in severe eosinophilic asthma beyond clinical outcomes — Europe PMC PMID:42440605 — Europe PMC (en), https://europepmc.org/article/MED/42440605 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_09c6df2b52bb (Metraipolis archive dc_09c6df2b52bb, sha256 ff0a59dc133c7737692abd2a71815f756cde48ab29d617db9b35382a1c1de7c0)
BibTeX
@misc{dc09c6df2b52bb,
  title = {Systemic immunologic effects of long-term dupilumab treatment in severe eosinophilic asthma beyond clinical outcomes — Europe PMC PMID:42440605},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42440605},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_09c6df2b52bb; sha256 ff0a59dc133c7737692abd2a71815f756cde48ab29d617db9b35382a1c1de7c0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42440605. Agents can read the archived copy with the MCP tool read_document.